2023 CAA Executive Summary and Update

This Post is reserved for Members only.

More to explore

RxDC Reporting 2025: To Submit or Not Submit

April 3, 2025 No Comments

What’s so important about the decision to submit your RxDC Drug Cost Reporting and why you want to access your data?

From Reporting to Benchmarking: Ensuring Complete CAA Compliance

June 5, 2024 No Comments

With the recent passing of the June 1 deadline for reporting Consolidated Appropriations Act (CAA) required prescription drug data to government agencies,

A person in scrubs is holding a tablet computer that displays a 3D holographic image of a heart. Text on the screen includes medical jargon in Cyrillic and Latin characters. The background appears to be a futuristic medical bay or computer lab.

The Rise of Data Evolution: How the CAA is Redefining Healthcare Decision-Making

April 1, 2024 No Comments

In the ever-evolving landscape of healthcare, access to comprehensive data is a game-changer, offering unparalleled insights into utilization and cost. One significant

Tony Sorrentino

2023 CAA Executive Summary and Update

More to explore

RxDC Reporting 2025: To Submit or Not Submit

From Reporting to Benchmarking: Ensuring Complete CAA Compliance

The Rise of Data Evolution: How the CAA is Redefining Healthcare Decision-Making

Resources

Company